VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 126 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $253,000 | -34.3% | 53,800 | 0.0% | 0.00% | – |
| Q4 2020 | $385,000 | -32.9% | 53,800 | 0.0% | 0.00% | – |
| Q3 2020 | $574,000 | -15.5% | 53,800 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $679,000 | +40.0% | 53,800 | +1.5% | 0.00% | 0.0% |
| Q1 2020 | $485,000 | -34.4% | 53,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $739,000 | -17.1% | 53,000 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $891,000 | -28.1% | 51,800 | +13.8% | 0.00% | 0.0% |
| Q2 2019 | $1,239,000 | +83.3% | 45,500 | +28.9% | 0.00% | 0.0% |
| Q1 2019 | $676,000 | +103.6% | 35,300 | 0.0% | 0.00% | – |
| Q4 2018 | $332,000 | -50.3% | 35,300 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $668,000 | -3.2% | 35,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $690,000 | +25.0% | 35,300 | +20.1% | 0.00% | 0.0% |
| Q1 2018 | $552,000 | +13.1% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $488,000 | – | 29,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| GLOBEFLEX CAPITAL L P | 36,109 | $278,400 | 0.03% |